CNO officer plans $511K stock sale, 9,336 shares

Rhea-AI Filing Summary

CNO Financial Group, Inc. (CNO) disclosed that officer Karen DeToro filed a notice to sell CNO common stock under Rule 144. She lists 9,336 shares of common stock held through Morgan Stanley Smith Barney Executive Financial Services, with an indicated value of $511,002.96 as of September 1, 2026. Planned sales include 1,836 shares from restricted stock dated March 25, 2025 and 7,500 shares issuable upon a stock option exercise dated September 1, 2026. The notice also reports a prior sale of 9,374 shares on August 31, 2026 for $515,366.21.

Key Figures

Shares held via broker: 9,336 shares Indicated value of shares: $511,002.96 Restricted stock to be sold: 1,836 shares +3 more

6 metrics

Shares held via broker 9,336 shares CNO common stock position listed with Morgan Stanley Smith Barney Executive Financial Services

Indicated value of shares $511,002.96 Aggregate value of 9,336 CNO common shares as of September 1, 2026

Restricted stock to be sold 1,836 shares CNO restricted stock dated March 25, 2025 listed as securities to be sold

Stock option exercise shares to be sold 7,500 shares CNO common shares issuable from a stock option exercise dated September 1, 2026

Recent sale shares 9,374 shares CNO common shares sold on August 31, 2026

Proceeds from recent sale $515,366.21 Aggregate proceeds from 9,374 CNO shares sold on August 31, 2026

Key Terms

Rule 144, Restricted Stock, Stock Option Exercise, Securities To Be Sold

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock financial

"Common | 03/25/2025 | Restricted Stock | ISSUER"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Stock Option Exercise financial

"Common | 09/01/2026 | Stock Option Exercise | ISSUER"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Securities To Be Sold financial

"144: Securities To Be Sold"

FAQ

What insider sale is being reported for CNO on this Form 144?

Officer Karen DeToro filed to sell CNO common stock under Rule 144, listing 9,336 shares held, with planned sales from 1,836 restricted shares and 7,500 shares from a stock option exercise, plus disclosure of a prior 9,374-share sale.

How many CNO shares does Karen DeToro plan to sell under this notice?

The notice lists planned sales of 1,836 shares of restricted stock dated March 25, 2025 and 7,500 shares from a stock option exercise dated September 1, 2026, for a total of 9,336 shares referenced in the broker-held position.

What was the recent CNO stock sale disclosed by Karen DeToro?

The filing reports that Karen DeToro sold 9,374 shares of CNO common stock on August 31, 2026 for aggregate proceeds of $515,366.21, and this transaction is disclosed in the section covering securities sold during the past three months.

What is the reported market value of the CNO shares held for sale?

The filing shows that 9,336 CNO common shares held through Morgan Stanley Smith Barney Executive Financial Services have an indicated value of $511,002.96 as of September 1, 2026, based on the data provided in the securities information section.

What types of CNO equity awards are involved in Karen DeToro’s planned sales?

The planned CNO sales involve restricted stock and shares from a stock option exercise. Specifically, 1,836 shares are from restricted stock dated March 25, 2025, and 7,500 shares are tied to a stock option exercise dated September 1, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 04:11 PM Accepted by SEC EDGAR 09/01/2026 - 04:11 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001789577
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CNO FINANCIAL GROUP, INC.
SEC File Number	001-31792
Address of Issuer	11299 Illinois Street Carmel INDIANA 46032
Phone	(317) 817-6100
Name of Person for Whose Account the Securities are To Be Sold	KAREN DETORO
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	9336	511002.96	92521371	09/01/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/25/2025	Restricted Stock	ISSUER			1836	03/25/2025	Not Applicable
Common	09/01/2026	Stock Option Exercise	ISSUER			7500	09/01/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
KAREN DETORO 11299 Illinois Street Carmel IN 46032	Common	08/31/2026	9374	515366.21

144: Remarks and Signature

Remarks
Date of Notice	09/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Karen J DeToro
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)